Primary Care CKD Registry

Hypertension Clinical Trial

Official title:

Impact of a Safety-Net Primary Care CKD Registry

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03473509
• Other study ID #: R34DK093992
• Status: Completed
• Phase: N/A
• First received: March 9, 2018
• Last updated: March 20, 2018
• Start date: June 2013
• Est. completion date: March 2015

Study information

• Verified date: March 2018
• Source: University of California, San Francisco
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study examines whether a safety-net primary care CKD registry directed at the entire primary care team can enhance the delivery of guideline concordant CKD care, including BP control, ACEi/ARB use and albuminuria quantification.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 746
• Est. completion date: March 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

All PCPs who worked in practice teams and provided longitudinal primary care to patients were eligible to participate in this study. Practice teams that consisted of several physicians (+/- trainees), one nurse, nurse practitioners, medical assistants and behaviorists, were randomized 1:1 to one of two arms with a random number generator: access to an electronic CKD registry or a usual care registry for 12 months.

Exclusion Criteria:

PCPs who solely provided specialty care, for example HIV services or urgent care, were excluded.

Related Conditions & MeSH terms

• Chronic Kidney Diseases
• Hypertension
• Kidney Diseases
• Renal Insufficiency, Chronic

Intervention

Other:
• CKD Registry
Health Service intervention

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Francisco

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in clinic systolic	Change in ambulatory systolic BP measured at ambulatory clinic visits in the health care system.	12 months
Secondary	Change in proportion of patients with BP control	Change in the proportion of patients with BP control defined by BP <140/<90 mmHg at an ambulatory clinic visit.	12 months
Secondary	Change in proportion fo patients with urine albuminuria quantification	Change in proportion of patients whose albuminuria was quantified by a urine test among those had not received quantification at trial initiation.	12 months
Secondary	Change in albuminuria severity	Change in albuminuria severity (mg urine albumin/g urine creatinine) among those patients with albuminuria quantified at trial initiation	12 months
Secondary	Change in proportion of patients with ACEi/ARB prescription	Change in proportion of patients prescribed an ACEi/ARB in the clinical record or had a documented reason for no prescription (i.e., allergy, prior development of hyperkalemia, or acute kidney injury)	12 months